Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH

Peptides

Volumn 18, Issue 6, 1997, Pages 885-891

  Arvat, Emanuela ^d   Di Vito, Lidia ^d   Maccagno, Barbara ^d   Broglio, Fabio ^d   Boghen, Muni F ^a   Deghenghi, Romano ^b   Camanni, Franco ^d   Ghigo, Ezio ^c  

^a Pharmacia   (Italy)

^b Ardana   (France)

^c MOLINETTE HOSPITAL   (Italy)

^d NONE

Author keywords

ACTH; Cortisol; GH; GHRP 2; Hexarelin; PRL

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR 2; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; HEXARELIN; HYDROCORTISONE; PROLACTIN; PROTIRELIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DOSE RESPONSE; GROWTH HORMONE RELEASE; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; AGING; CORTICOTROPIN-RELEASING HORMONE; FLUSHING; GROWTH HORMONE-RELEASING HORMONE; GROWTH SUBSTANCES; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; MALE; OLIGOPEPTIDES; PITUITARY HORMONE-RELEASING HORMONES; PROLACTIN; THYROTROPIN-RELEASING HORMONE;

EID: 0030852329     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00016-8     Document Type: Article

References (42)

1. Aloi J. A., Gertz B. J., Hartman M. L., Huhn W. C., Pezzoli S. S., Wittreich M., Krupa D. A., Thorner M. O. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects. J. Clin. Endocrinol. Metab. 79:1994;943-949.
2. Arvat E., Gianotti L., Di Vito L., Imbimbo B. P., Lenaerts V., Deghenghi R., Camanni F., Ghigo E. Modulation of growth hormone-releasing activity of hexarelin in man. Neuroendocrinology. 61:1995;51-56.
3. Arvat E., Gianotti L., Grottoli S., Imbimbo B. P., Lenaerts V., Deghenghi R., Camanni F., Ghigo E. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. J. Clin. Endocrinol. Metab. 79:1994;1440-1443.
4. Badger T. M., Millard W. Y., McCormik G. F., Bowers C. Y., Martin J. B. The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats. Endocrinology. 115:1984;1432-1438.
5. Bowers C. Y., Reynolds G. A., Durham D., Barrera C. M., Pezzoli S. S., Thorner M. O. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J. Clin. Endocrinol. Metab. 70:1990;975-982.
6. Bowers C. Y., Sartor A. O., Reynolds G. A., Badger T. M. On the action of the growth hormone-releasing hexapeptide, GHRP. Endocrinology. 128:1991;2027-2035.
7. Bowers C. Y. GH releasing peptides. Structure and kinetics. J. Pediatr. Endocrinol. 6:1993;21-31.
8. Bowers C. Y., Veeraragavan K., Sethumadhavan K. Atypical growth hormone releasing peptides. Bercu B. B., Walker R. F. Growth Hormone II, Basic and Clinical Aspects. 1993;203-222 Springer-Verlag, New York.
9. Bowers, C. Y.; Reynolds, G. A.; Field, G.; Arkieh, A.; Kaf-Alghazal, A.; Krishnamurthi, L.; Granda-Ayala, R. Independency, dependency and synergism of GHRP-2 and GHRH on GH release in humans. 10th Intern Congress of Endocrinol; 1996:770 (abstract).
10. 2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3′,5′-monophosphate accumulation in rat primary cell culture. Endocrinology. 124:1989;2791-2798.
11. Ciccarelli E., Grottoli S., Razzore P., Gianotti L., Arvat E., Deghenghi R., Camanni F., Ghigo E. Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinemia patients. Clin. Endocrinol. 44:1996;67-71.
12. Clark R. G., Carisson M. S., Trojnar J., Robinson I. C. A. F. The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anaesthetized rats. J. Neuroendocrinol. 1:1989;252-255.
13. Codd E. E., Shu A. Y. L., Walker R. F. Binding of a growth hormone releasing hexapaptide to specific hypothalamic and pituitary binding sites. Neuropharmacology. 28:1989;1139-1144.
14. Conley L. K., Teik J. A., Deghenghi R., Imbimbo B. P., Giustina A., Locatelli V., Wehernberg W. B. Mechanism of action of Hexarelin and GHRP-6: analysis of the involment of GHRH and somatostatin in the rat. Neuroendocrinology. 61:1995;44-50.
15. Copinschi G., van Onderberghen A., L'hermite-Baleriaux M., Mendel C. M., Caufriez A., Leproult R., Bolognese J. A., De Smet M., Thorner M. O., van Cauter E. Effects of 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men. J. Clin. Endocrinol. Metab. 81:1996;2776-2782.
16. Corpas E., Harman S. M., Blackman G. Human growth hormone and human aging. Endocr. Rev. 14:1993;20-39.
17. Deghenghi R., Boutignon F., Luoni M., Grilli R., Guidi M., Locatelli V. Small peptides as potent releasers of growth hormone. J. Ped. Endocrinol. Metab. 8:1995;311-313.
18. Dickson S. L., Leng G., Robinson I. C. A. F. Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons. Neurosci. Lett. 53:1993;303-307.
19. Fairhall K M., Mynett A., Robinson I. C. A. F. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. J. Endocrinol. 144:1995;555-560.
20. Gertz B. J., Barrett J. S., Eisenhandler R., Krupa D. A., Wittreich J. M., Seibold J. R., Schneider S. H. Growth hormone response in man to L-692,429, a novel non-peptide mimic of growth hormone-releasing peptide-6. J. Clin. Endocrinol. Metab. 77:1993;1393-1397.
21. Ghigo E., Arvat E., Goffi S., Bellone J., Nicolosi M., Procopio M., Maccario M., Camanni F. Neural control of growth hormone secretion in aged humans. Muller E. E., Cocchi D., Locatelli V. Growth Hormone and Somatomedins During Lifespan. 1993;275-287 Springer-Verlag, Berlin.
22. Ghigo E., Arvat E., Gianotti L., Imbimbo B. P., Lenaerts V., Deghenghi R., Camanni F. Growth hormone-releasing activity of Hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal and oral administration in man. J. Clin. Endocrinol. Metab. 78:1994;693-698.
23. Ghigo E., Arvat E., Rizzi G., Bellone J., Nicolosi M., Boffano G. M., Mucci M., Boghen M. F., Camanni F. Arginine enhances the growth hormone (GH)-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration. J. Endocrinol. Invest. 17:1994;157-162.
24. Ghigo E., Arvat E., Rizzi G., Goffi S., Mucci M., Boghen M. F., Camanni F. Growth hormone-releasing activity of growth hormone-releasing peptide-6 is mantained after short-term oral pretreatment with the hexapeptide in normal aging. Eur. J. Endocrinol. 131:1994;1-4.
25. Ghigo E., Arvat E., Gianotti L., Grottoli S., Rizzi G., Ceda G. P., Deghenghi R., Camanni F. Aging and GH-releasing peptides. Bercu B., Walker R. Growth Hormone Secretagogues. 1996;415-431 Serono Symposia, New York.
26. Goth M I., Lyons C. E., Canny B. J., Thorner M. O. Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology. 130:1992;939-944.
27. Guillame V., Magnan E., Cataldi M., Dutour A., Sauze N., Renard M., Razafindraibe H, Conte-Devolx B., Deghenghi R., Lanaerts V., Oliver C. Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology. 135:1994;1073-1076.
28. Hartman M. L., Farello G., Pezzoli S. S., Thorner M. O. Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men. J. Clin. Endocrinol. Metab. 74:1992;1378-1384.
29. Howard A. D., Feighner S. D., Cully D. F., Arena J. P., Liberator P. A., Rosenblum C. I., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 273:1996;974-977.
30. Ilson B. E., Jorkasky D. K., Curnow R. T., Stote R. M. Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. J. Clin. Endocrinol. Metab. 69:1989;212-214.
31. Imbimbo B. P., Mant T., Edward M., Amin D., Froud A., Lenaerts U., Boutignon F., Deghenghi R. Growth hormone releasing activity of hexarelin in humans: A dose-response study. Eur. J. Clin. Pharmacol. 46:1994;421-425.
32. Korbonits M., Trainer P. J., Besser G. M. The effect of an opiate antagonist on the hormonal changes induced by hexarelin. Clin. Endocrinol. 43:1995;365-371.
33. Loche S., Cambiaso P., Merola B., Colao A., Faedda A., Imbimbo B. P., Deghenghi R., Lombardi G., Cappa M. The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency. J. Clin. Endocrinol. Metab. 80:1995;2692-2696.
34. Maccario M., Arvat E., Procopio M., Gianotti L., Grottoli S., Imbimbo B. P., Lenaerts V., Deghenghi R., Camanni F., Ghigo E. Metabolic modulation of the growth-hormone-releasing activity of hexarelin in man. Metabolism. 44:1995;134-138.
35. 2 (GHRP6)-induced GH secretion in the rat. Neuroendocrinology. 57:1992;247-251.
36. Muccioli, G.; Ghe', C.; Ghigo, M. C.; Arvat, E.; Papotti, M.; Boghen, M. F.; Deghenghi, R.; Ong, H.; Ghigo, E. Presence of specific receptors for Hexarelin, a GH releasing hexapeptide, in human brain and pituitary gland. International symposium growth factors in Endocrinology and Metabolism. Berlin; 1995:110 (abstract).
37. Muller E. E., Nistico' G. Neurohormonal control of anterior pituitary hormones. Muller E. E., Nistico' G. Brain Messengers and the Pituitary. 1989;404-537 Academic Press, San Diego.
38. Penalva A., Carballo A., Pombo M., Casanueva F. F., Dieguez C. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. J. Clin. Endocrinol. Metab. 76:1993;168-171.
39. Popovic V., Damjanovic S., Micic D., Djurovic M., Dieguez C., Casanueva F. F. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: Evidence that GHRP-6 main action is exerted at the hypothalamic level. J. Clin. Endocrinol. Metab. 80:1995;942-947.
40. 2 in rat primary pituitary cell monolayer culture. Endocrinology. 116:1985;952-957.
41. Tuilpakov A. N., Brook C. G., Pringle P., Peterkova V. A., Volevodz N. N., Bowers C. Y. GH responses to intravenous bolus infusions of GH releasing hormone and GH releasing peptide 2 separately and in combination in adult volunteers. Clin. Endocrinol. 43:1995;347-350.
42. Veeragavan K., Sethumadhavan K., Bowers C. Y. Growth hormone-releasing peptide (GHRP) binding to porcine anterior pituitary and hypothalamic membranes. Life Sci. 50:1992;1149-1155.